(84 days)
No
The 510(k) summary describes a mechanical transfer option for moving patients between imaging systems. There is no mention of AI or ML in the intended use, device description, or performance studies.
No.
The device is intended to be utilized by appropriately trained healthcare professionals to aid in the detection, localization, and diagnosis of diseases and disorders. It does not provide therapy or treatment.
Yes
The document explicitly states that the Siemens MR-PET system is intended "to aid in the detection, localization, and diagnosis of diseases and disorders" and "combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners". It also describes the MR's function to "produce... MR images... and displays the internal structure and/or function of the human body" and the PET's function to "aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders". These are all functions of a diagnostic device.
No
The device description explicitly details several hardware components (Transferboard, Guiding Slide Way, Coil Adapter Cover, Patient Cushion, Fixation Belts, Transfer Support Cart) that are part of the new option being introduced. While software is mentioned as a requirement, the device itself is a system incorporating significant physical components for patient transfer.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Siemens MR-PET system and the mMR Angio Transfer Option are imaging devices and patient transfer systems. They acquire images of the internal structure and function of the human body using MR and PET technologies. They do not perform tests on samples taken from the body.
- Intended Use: The intended use describes aiding in the detection, localization, and diagnosis of diseases and disorders through imaging and the transfer of patients for these imaging procedures. This is consistent with medical imaging devices, not IVDs.
The device is a medical imaging system and a related patient transfer accessory, not a diagnostic test performed on biological samples.
N/A
Intended Use / Indications for Use
The Siemens MR-PET system combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners that provide registration and fusion of high resolution physiologic and anatomic information, acquired simultaneously and isocentrically. The combined system maintains independent functionality of the MR and PET devices, allowing for single modality MR and / or PET imaging.
These systems are intended to be utilized by appropriately trained health care professionals to aid in the detection, localization, and diagnosis of diseases and disorders.
The MR is intended to produce transverse, sagittal, coronal and oblique crosssectional MR images, spectroscopic images and/or spectra, and displays the internal structure and/or function of the human body. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, approved contrast agents may be used, as described in their labeling. This system may also be used for imaging during interventional procedures wen performed with MR compatible devices, such as MR safe biopsy needles.
The PET images and measures the distribution of PET radiopharmaceuticals in humans to aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer.
The combined system utilizes the MR for radiation correction maps for PET studies. The system provides inherent anatomical reference for the fissed PET and MR images due to precisely aligned MR and PET image coordinate systems.
Product codes (comma separated list FDA assigned to the subject device)
OUO, LNH, LNI, KPS
Device Description
The new mMR Angio Transfer Option is being introduced for the Biograph mMR system.
The new option is intended to provide a patient transfer from the SIEMENS Artis Q and Artis Q.zen (K123529) or Artis zee/zeego SW VC21 (K141574) System to the Biograph mMR and vice versa.
To achieve this functionality a Transferboard Artis (further named as Transferboard) will be used where the patient is located and transferred. This Transferboard can be adapted on the standard table of the Artis Q and Artis Q.zen (K123529) or Artis zee/zeego SW VC21 (K141574) System. The standard table is identical for all models. By swiveling the Artis Q. Artis Q.zen or Artis zee /zeego table (standard function) the Transferboard will be positioned in front of the Biograph mMR. Via the Guiding Slide Way the Transferboard is pushed manually on the Table Top of the Biograph mMR.
The Guiding Slide Way is also included in the option and is installed on the Table Top of the Biograph mMR instead of a regular patient cushion.
The Transferboard is also used to move the patient into the bore of the Biograph mMR for further diagnostic imaging.
The basic device and its functionality remain unchanged except for the following modifications:
- . Coil Adapter Cover (CAC): The Coil Adapter Cover will replace the standard mMR coil adapter cover on the foot end of the mMR tabletop to enable the overtraveling of the Transferboard (TFB).
- Guiding Slide Wav (GSW): A Guiding Slide Way (GSW) will be adapted on the ● existing Biograph mMR tabletop. This is a foldable option and can be removed for diagnostic mMR examination in case the transfer option is not needed.
- Transferboard (TFB): The Transferboard (TFB) is intended to transfer the ● patient. The patient remains on this board during the whole intraoperative procedure.
- Patient Cushion (LGH): The Patient Cushion is laid on the Transferboard (TFB) for comfortable reclining.
- Fixation Belts: The Fixation Belts are used for preventing the patient to fall of ● the Transferboard and Patient Cushion during transport, surgery and imaging,
- Transfer Support Cart (TSC): The Transfer Support Cart is part of the option. ● It ensures that both tables have the same height and that there are no vibrations during transfer due to load changes on the patient tables
The new mMR Angio Transfer Option for the Biograph mMR system requires the most recent Device Software, syngo MR E11P software cleared via 510(k) on February 28, 2017 (K163234).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Magnetic Resonance (MR), Positron Emission Tomography (PET)
Anatomical Site
human body
Indicated Patient Age Range
Not Found
Intended User / Care Setting
appropriately trained health care professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical Performance Testing:
- Mechanical Test according to IEC 60601-1 / ANSI AAMI ES 60601-1
- System verification and validation.
Key Results: The results from each set of tests demonstrate that the device performs as intended and is thus substantially equivalent to the predicate devices to which it has been compared. mMR Angio Transfer Option for the Biograph mMR conforms to the applicable FDA recognized and international IEC, ISO and NEMA standards with regards to performance and safety as recommended by the respective MR FDA Guidance Document, "Guidance for the Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices", issued in 2016.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the text "FDA U.S. FOOD & DRUG ADMINISTRATION" on the right. The symbol on the left is a stylized image of a caduceus, which is a traditional symbol of medicine. The text on the right is written in a clear, sans-serif font, with "FDA" in a larger font size than the rest of the text.
Siemens Medical Solutions USA, Inc. Cordell Fields Regulatory Affairs Specialist 65 Valley Stream Parkway, Mail Code 65-1A Malvern, Pennsylvania 19355
Re: K172531
Trade/Device Name: Biograph mMR with mMR Angio Transfer Option Regulation Number: 21 CFR 892.1200 Regulation Name: Emission Computed Tomography System Regulatory Class: Class II Product Code: OUO, LNH, LNI, KPS Dated: August 21, 2017 Received: August 22, 2017
Dear Cordell Fields:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
November 14, 2017
1
Page 2 - Cordell Fields
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael D. O'Hara For
Robert A. Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Image /page/2/Picture/0 description: The image shows the word "SIEMENS" in a bold, sans-serif font. The color of the text is a bright teal. The background is white, providing a strong contrast that makes the text stand out. The letters are evenly spaced and appear to be part of a logo or branding element.
Section 4: Indications for Use Statement
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration.
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.
510(k) Number (if known)
Device Name Biograph mMR with mMR Angio Transfer Option
Indications for Use (Describe)
The Siemens MR-PET system combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners that provide registration and fusion of high resolution physiologic and anatomic information, acquired simultaneously and isocentrically. The combined system maintains independent functionality of the MR and PET devices, allowing for single modality MR and / or PET imaging.
These systems are intended to be utilized by appropriately trained health care professionals to aid in the detection, localization, and diagnosis of diseases and disorders.
The MR is intended to produce transverse, sagittal, coronal and oblique crosssectional MR images, spectroscopic images and/or spectra, and displays the internal structure and/or function of the human body. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, approved contrast agents may be used, as described in their labeling. This system may also be used for imaging during interventional procedures wen performed with MR compatible devices, such as MR safe biopsy needles.
The PET images and measures the distribution of PET radiopharmaceuticals in humans to aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer.
The combined system utilizes the MR for radiation correction maps for PET studies. The system provides inherent anatomical reference for the fissed PET and MR images due to precisely aligned MR and PET image coordinate systems.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995, *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW." The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." FORM FDA 3881 (7/17) Page 1 of 1 PSC Publishing Services (301) 443-6740
3
Image /page/3/Picture/1 description: The image shows the word "SIEMENS" in a bold, sans-serif font. The color of the text is a bright teal. The word is presented in all capital letters and is centered in the image.
Section 5 510(k) Summary
Biograph mMR with mMR Angio Transfer Option
| Company Name
and Address | Siemens Medical Solutions USA. Inc.
40 Liberty Boulevard
Mail Code 65-1A
Malvern, PA 19355, USA
Registration Number: 2240869 |
|-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date Prepared | August 21, 2017 |
| Conformance
statement: | This 510(k) summary of safety and effectiveness information is
being submitted in accordance with the requirements of the
Safe Medical Device Act of 1990 and 21 CFR § 807.92. |
1. General Information
| Importer / Distributor | Siemens Medical Solutions USA. Inc.
40 Liberty Boulevard
Mail Code 65-1A
Malvern, PA 19355, USA
Registration Number: 2240869 |
| ------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------ |
|---|
| Location of | Siemens Healthcare GmbH |
|---|---|
| Manufacturing | Henkestrasse 127 |
| Site | Erlangen Bayern, Germany 91052 |
| Registration Number: 3002808157 |
4
Image /page/4/Picture/0 description: The image shows the word "SIEMENS" in a teal, sans-serif font. The letters are bold and evenly spaced. The background is plain white, which makes the word stand out.
2. Contact Persons
| Contact Person | Cordell L. Fields, Esq.
Regulatory Affairs Technical Specialist
Siemens Medical Solutions USA, Inc.
65 Valley Stream Parkway
Mail Code 65-1A
Malvern, PA 19355, USA
Phone: (610) 448-6469
Cell: (610) 306-3167
Fax: (610) 640-4481
E-mail: cordell.fields@siemens-healthineers.com |
|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Alternate Contact
Person | Kimberly Rendon |
| | Sr. Manager Regulatory Affairs |
| | Siemens Medical Solutions USA, Inc. |
| | 65 Valley Stream Parkway |
| | Mail Code 65-1A |
| | Malvern, PA 19355, USA |
| | Phone: (610) 448-6480 |
| | Fax: (610) 448-1787 |
| | E-mail: Kimberly.rendon@siemens-healthineers.com |
3. Device Name and Classification
| Trade Name: | Biograph mMR with mMR Angio Transfer Option |
|---|---|
| Classification Name | Tomographic Imager Combining Emission Computed |
| Tomography with Nuclear Magnetic Resonance | |
| Classification Panel: | Radiology |
| Classification | |
| Regulation | 21 CFR § 892.1200 |
| 21 CFR § 892.1000 | |
| Device Class: | II |
| Primary Product | |
| Code: | OUO |
| Secondary Product | |
| Codes: | LNH, LNI, KPS |
5
4. Legally Marketed Predicate Devices
| Trade Name | Biograph mMR with Software syngo
MR E11P |
|------------------------------|----------------------------------------------------------------------------------------------|
| 510(k) # | K163234 cleared February 28, 2017 |
| Classification Name | Tomographic Imager Combining Emission Computed
Tomography with Nuclear Magnetic Resonance |
| Classification Panel: | Radiology |
| Classification
Regulation | 21 CFR § 892.1200
21 CFR § 892.1000 |
| Device Class: | II |
| Primary Product
Code: | OUO |
| Secondary Product
Codes: | LNH, LNI, KPS |
| Recall Information | "There are no Recalls for this Predicate Device." |
5. Device Description
The new mMR Angio Transfer Option is being introduced for the Biograph mMR system.
The new option is intended to provide a patient transfer from the SIEMENS Artis Q and Artis Q.zen (K123529) or Artis zee/zeego SW VC21 (K141574) System to the Biograph mMR and vice versa.
To achieve this functionality a Transferboard Artis (further named as Transferboard) will be used where the patient is located and transferred. This Transferboard can be adapted on the standard table of the Artis Q and Artis Q.zen (K123529) or Artis zee/zeego SW VC21 (K141574) System. The standard table is identical for all models. By swiveling the Artis Q. Artis Q.zen or Artis zee /zeego table (standard function) the Transferboard will be positioned in front of the Biograph mMR. Via the Guiding Slide Way the Transferboard is pushed manually on the Table Top of the Biograph mMR.
The Guiding Slide Way is also included in the option and is installed on the Table Top of the Biograph mMR instead of a regular patient cushion.
6
Image /page/6/Picture/1 description: The image shows the word "SIEMENS" in a bold, sans-serif font. The letters are a bright teal color. The background is plain white, which makes the word stand out.
The Transferboard is also used to move the patient into the bore of the Biograph mMR for further diagnostic imaging.
The basic device and its functionality remain unchanged except for the following modifications:
- . Coil Adapter Cover (CAC): The Coil Adapter Cover will replace the standard mMR coil adapter cover on the foot end of the mMR tabletop to enable the overtraveling of the Transferboard (TFB).
- Guiding Slide Wav (GSW): A Guiding Slide Way (GSW) will be adapted on the ● existing Biograph mMR tabletop. This is a foldable option and can be removed for diagnostic mMR examination in case the transfer option is not needed.
- Transferboard (TFB): The Transferboard (TFB) is intended to transfer the ● patient. The patient remains on this board during the whole intraoperative procedure.
- Patient Cushion (LGH): The Patient Cushion is laid on the Transferboard (TFB) for comfortable reclining.
- Fixation Belts: The Fixation Belts are used for preventing the patient to fall of ● the Transferboard and Patient Cushion during transport, surgery and imaging,
- Transfer Support Cart (TSC): The Transfer Support Cart is part of the option. ● It ensures that both tables have the same height and that there are no vibrations during transfer due to load changes on the patient tables
The new mMR Angio Transfer Option for the Biograph mMR system requires the most recent Device Software, syngo MR E11P software cleared via 510(k) on February 28, 2017 (K163234).
Advantage
The new features on the Biograph mMR with mMR Angio Transfer Option enables the handover of a patient previously examined by SIEMENS Artis Q. Artis Q.zen or Artis zee/zeego System and vice versa. The advantage is that the patient can simply stay on the Transfer Board. There is no need to lift him or her from one patient support system to another.
7
Image /page/7/Picture/1 description: The image shows the word "SIEMENS" in a bold, sans-serif font. The color of the text is a bright teal. The letters are evenly spaced and the word is horizontally oriented.
6. Indication for Use
The indications for use for the subject device are the same as the predicate device and are as follows:
The Siemens MR-PET system combines magnetic resonance diagnostic devices (MRDD) and Positron Emission Tomography (PET) scanners that provide reqistration and fusion of high resolution physiologic and anatomic information, acquired simultaneously and isocentrically. The combined system maintains independent functionality of the MR and PET devices, allowing for single modality MR and / or PET imaging.
These systems are intended to be utilized by appropriately trained health care professionals to aid in the detection, localization, and diagnosis of diseases and disorders.
The MR is intended to produce transverse, sagittal, coronal and oblique crosssectional MR images, spectroscopic images and/or spectra, and displays the internal structure and/or function of the human body. Other physical parameters derived from the images and/or spectra may also be produced. Depending on the region of interest, approved contrast agents may be used, as described in their labeling. This system may also be used for imaging during interventional procedures when performed with MR compatible devices, such as MR safe biopsy needles.
The PET images and measures the distribution of PET radiopharmaceuticals in humans to aid the physician in determining various metabolic (molecular) and physiologic functions within the human body for evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer.
The combined system utilizes the MR for radiation-free attenuation correction maps for PET studies. The system provides inherent anatomical reference for the fused PET and MR images due to precisely aligned MR and PET image coordinate systems.
Substantial Equivalence 7.
The subject device, mMR Angio Transfer Option for the Biograph mMR, was developed from the previous version of the Biograph mMR (with software version svnao MR E11P).
As described above, only the hardware for the device was modified. Software is not affected.
8
Image /page/8/Picture/1 description: The image shows the word "SIEMENS" in a sans-serif font. The word is written in all capital letters. The color of the text is a teal or cyan color.
8. Summary of Technological Characteristics of the Subject Device as Compared with the Predicate Device
Technological Characteristics
The new mMR Angio Transfer Option for the Biograph mMR has the same technological characteristics as the predicate device Biograph, mMR with syngo MR E11P (K163234, cleared February 28, 2017).
The subject device is substantially equivalent to the predicate device. As described above, the main changes are mechanical and enable the transfer of the patient form the Artis Q. Artis Q.zen or Artis zee/zeego System to the Biograph mMR.
9. Nonclinical Performance Testing
The following performance testing was conducted on the subject device for covering the mMR Angio Transfer Option for the Biograph mMR. Existing performance test for the Biograph mMR remain valid.
- Mechanical Test according to IEC 60601-1 / ANSI AAMI ES 60601-1 ●
- . System verification and validation.
The results from each set of tests demonstrate that the device performs as intended and is thus substantially equivalent to the predicate devices to which it has been compared.
mMR Angio Transfer Option for the Biograph mMR conforms to the applicable FDA recognized and international IEC, ISO and NEMA standards with regards to performance and safety as recommended by the respective MR FDA Guidance Document, "Guidance for the Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices", issued in 2016.
For the mMR Angio Transfer Option for the Biograph mMR, new testing for the standards indicated by an asterisk (*) was conducted for the proposed modifications. Standards not indicated by an asterisk are also tested for the Biograph mMR however their validity is not affected by the proposed modifications, i.e. the old evidence is still valid.
9
SIEMENS
| Recognition
Number | Product Area | Title of Standard | Reference
Number and
date | Standards
Development
Organization |
|-----------------------|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|------------------------------------------|
| * 19-4 | General | Medical electrical equipment –
part 1: general requirements
for basic safety and essential
performance | ES60601-
1:2005/(R) 2012
and A1:2012 | AAMI /
ANSI |
| 19-1 | General | Medical electrical equipment –
Part 1-2: General requirements
for basic safety and essential
performance – Collateral
standard: Electromagnetic
compatibility – Requirements
and tests | 60601-1-2 Edition
3:2007-03 | IEC |
| 12-271 | Radiology | Medical electrical equipment –
Part 2-33: Particular
requirements for the basic
safety and essential
performance of magnetic
resonance equipment for
medical diagnosis | 60601-2-33 Ed.
3.1:2013 | IEC |
| * 5-40 | General | Medical devices – Application
of risk management to medical
devices | 14971 Second
edition 2007-03-
01 | ISO |
| * 5-67 | General | Medical devices – Application
of usability engineering to
medical devices | 62366:2007 | IEC |
| 13-32 | Software | Medical device software –
Software life cycle processes | 62304:2006 | AAMI
ANSI
IEC |
| 12-232 | Radiology | Acoustic Noise Measurement
Procedure for Diagnosing
Magnetic Resonance Imaging
Devices | MS 4-2010 | NEMA |
| Recognition
Number | Product Area | Title of Standard | Reference
Number and
date | Standards
Development
Organization |
| 12-288 | Radiology | Characterization of Phased
Array Coils for Diagnostic
Magnetic Resonance Images
(MRI) | MS 9-2008 | NEMA |
| 12-300 | Radiology | Digital Imaging and
Communications in Medicine
(DICOM) Set 03/16/2012
Radiology | PS 3.1 – 3.20
(2016) | NEMA |
| 12-265 | Radiology | Performance measurements of
positron emission tomographs | NU 2-2012 | NEMA |
| * 2-220 | Biocompati
bility | Biological Evaluation Of
Medical Devices - Part 1:
Evaluation And Testing Within
A Risk Management Process | 10993-1 Fourth
Edition 2009-10-
15 | ISO |
10
Table 1: Recognized Consensus Standards for mMR Angio Transfer Option
10. General Safety and Effectiveness Concerns
Instructions for use are included in the device labeling, and the information provided will enable the user to operate the device in a safe and effective manner. Several safety features including visual and audible warnings are incorporated into the system design.
Also, the Biograph mMR with mMR Angio Transfer Option is continually monitored, and if an error occurs, the system functions will be blocked, and an error message will be displayed.
Risk management according to ISO 14971:2007 is ensured via a hazard analysis which is used to identify potential hazards. These potential hazards are controlled via software development, verification, and validation testing. To minimize electrical, mechanical, and radiation hazards, Siemens adheres to recognized and established industry practice, and all equipment is subject to final performance testing, Furthermore, the operators are health care professionals familiar with and responsible for the mMR examinations to be performed.
11
11. Conclusion as to Substantial Equivalence
mMR Angio Transfer Option for the Biograph mMR has the same intended use and the same technological characteristics as the predicate device Biograph mMR with syngo MR E11P (K163234).
The new features on the Biograph mMR with mMR Angio Transfer Option enables the handover of a patient previous examined by SIEMENS Artis Q. Artis Q.zen or Artis zee/zeego System and vice versa. The advantage is that the patient can simply stay on the Transfer Board. There is no need to lift the patient from one patient support system to another.
These modifications improve the user's workflow to enable an intraoperative procedure together with SIEMENS Artis Q and Artis Q.zen (K123529) or Artis zee/zeego SW VC21 (K141574) System.
The differences between the subject device and the predicate device include incorporation / adaptations of cleared features from the MAGNETOM Artis Combi Suite (K140253) which do not raise new issues of safety or effectiveness.
Therefore, Siemens believes that the subject device, Biograph mMR System with mMR Angio Transfer Option is substantially equivalent to the predicate device, Biograph mMR with syngo MR E11P.